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Abstract Not only the levels of individual metabolites,
but also the relations between the levels of different
metabolites may indicate (experimentally induced) changes
in a biological system. Component analysis methods in
current ‘standard’ use for metabolomics, such as Principal
Component Analysis (PCA), do not focus on changes in
these relations. We therefore propose the concept of
‘Between Metabolite Relationships’ (BMRs): common
changes in the covariance (or correlation) between all
metabolites in an organism. Such structural changes may
indicate metabolic change brought about by experimental
manipulation but which are lost with standard data analysis
methods. These BMRs can be analysed by the INdividual
Differences SCALing (INDSCAL) method. First the BMR
quantiﬁcation is described and subsequently the INDSCAL
method. Finally, two studies illustrate the power and the
applicability of BMRs in metabolomics. The ﬁrst study is
about the induced plant response of cabbage to herbivory,
of which BMRs are a considerable part. In the second
study—a human nutritional intervention study of green tea
extract—standard data analysis tools did not reveal any
metabolic change, although the BMRs were considerably
affected. The presented results show that BMRs can be
easily implemented in a wide variety of metabolomic
studies. They provide a new source of information to
describe biological systems in a way that ﬁts ﬂawlessly into
the next generation of systems biology questions, dealing
with personalized responses.
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1 Introduction
The relationships between different anatomical measure-
ments are a fundamental aspect of human physiology, as
has been elegantly depicted by Leonardo da Vinci in
his seminal work ‘The Vitruvian Man’ (da Vinci 1487;
Vitruvius 25 BC). This work shows these relationships are
highly conserved, even for men of variable length. This
ancient idea of describing relationships between different
properties has reached many other ﬁelds of research, for
example quantitative genetics (Steppan et al. 2002) and
individual differences psychology (Goldberg 1990).
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DOI 10.1007/s11306-011-0316-1Also the levels of many metabolites in a biological
system may be highly interrelated through the biochemical
pathways. Perturbations of these biological systems (e.g.
diet or disease) may alter enzyme activity and therefore the
link between different metabolites. However, the extent of
such alterations may also differ between individuals.
Thereby also in- or decreases of the inter-individual
metabolite level differences may indicate system change.
Then not only absolute metabolite level differences
between experimental groups, but also the relationships
between the metabolites may indicate change. Such
Between Metabolite Relationships (BMRs) therefore
describe an aspect of metabolism that is complementary to
the changes that are common to all individuals (Weckwerth
et al. 2004).
Recent advances in ‘omics’-research brought the study
of BMRs closer, because metabolomics emerges more and
more as a system-wide approach to observe metabolism
(Bino et al. 2004; Fiehn 2002; Hall 2006). The data of a
metabolomics study usually consists of a list of numerous
metabolites, of which the levels are given for every mea-
sured sample (e.g. individual and/or time-point). Of prime
interest to metabolomics studies may be to ﬁnd the in- or
decrease of speciﬁc metabolite levels between different
groups of individuals (e.g. before and after an experimental
perturbation) (Fig. 1a). However, this paradigm holds a
major shortcoming for the system-wide view provided by
metabolomics analyses, because it may disregard metabo-
lite combinations that show interesting variation where the
individual metabolites do not.
Univariate methods that quantify level changes of
individual metabolites (e.g., ANalysis Of VAriance,
ANOVA (Sokal and Rohlf 1995)) disregard the interrela-
tions between levels of different metabolites and thereby
the system-wide aspect of metabolism. Therefore in gen-
eral multivariate methods are used to analyse data gener-
ated in metabolomics studies, mostly those from the
‘Component Analysis’ family such as PCA and PLS-DA
(Barker and Rayens 2003, Jolliffe 2002). These summarize
data into a small number of ‘components’—latent variables
that gather information about the importance of all mea-
sured metabolites. These proﬁles are constructed based on
the levels of all metabolites and express the relative
importance of every metabolite in combination with all
other metabolites. PCA or PLS-DA models in e.g. case–
control studies enable to describe differences in metabolite
combinations between groups, even if the levels of single
metabolites are not signiﬁcantly different (Fig. 1b).
However, neither ANOVA nor PLS-DA explicitly
reveals the changes in the relationships between metabo-
lites in different experimental groups. Also unsupervised
methods like PCA (Jolliffe 2002) may be insufﬁcient to
describe BMRs, because these methods cover all metabolic
variation simultaneously. The BMRs—schematically
depicted in Fig. 1c—usually remain entangled with other
sources of metabolic change and remain beyond reach of
any method in these two metabolomic paradigms.
Several studies focus on relations between metabolites
(Steuer 2006), enzymes and genes (van Erk et al. 2010;
Zhai et al. 2010). These studies visualise such relations by
Correlation Networks that show the relationships between
all metabolite/enzymes/genes pairs (Steuer et al. 2003).
However, as already mentioned ‘Due to the sheer number
of pairwise metabolic correlations, large overview network
graphs easily get incomprehensible’ (Weckwerth et al.
2004) which is speciﬁcally relevant in metabolomics.
Therefore a method that both speciﬁcally focuses on BMRs
and is based on interpretable components that describe the
behaviour of the entire system (i.e. all pairwise metabolite
relations together) is required. It will provide a novel and
complementary view on metabolism.
In the ﬁeld of individual differences psychology, a
component method appropriate for the analysis of BMRs
called Individual Differences Scaling (INDSCAL) is
already available (Carroll 1981). This method translates the
changes in covariance or correlations between metabolites
upon experimental manipulation into a series of scores
and loadings, analogous to those from PCA or PLS-DA.
A voluminous yet well-readable publication reveals that
INDSCAL is a special version of Parallel Factor Analysis
Fig. 1 Three paradigms to observe metabolic differences between
two groups: a Level difference of an individual metabolite (e.g.
ANOVA), b Level difference in a combination of, i.e. a component of
more metabolites (e.g. PLS), c Changes in the combined relationship
between metabolites (INDSCAL)
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123(PARAFAC) (Harshman and Lundy 1984).
1 The PARA-
FAC model has been used earlier to solve a range of
questions in metabolomics studies that focused on changes
in metabolite proﬁles, see e.g. (Montoliu et al. 2009; Jansen
et al. 2008; Forshed et al. 2007; Sinha et al. 2004;
Verouden et al. 2009) and will therefore provide a view on
BMRs intuitive to metabolomics researchers.
First BMRs and the INDSCAL model are presented.
Then two metabolomics data sets are analysed with IND-
SCAL, one with a very prominent response of plant
chemistry to herbivory and another with a much more
subtle response of obese humans to catechin-enriched
green tea extract (GTE). The results of standard data
analysis methods used in metabolomics, such as ANOVA,
PCA, and PLS-DA are compared to that of INDSCAL.
2 Theory
In metabolomics experiments, one or more experimental
factors can be manipulated (e.g. doses of a toxicant, dif-
ferent populations) to observe their effect on the metabo-
lites present in an organism, often on different time-points
after the manipulation. Metabolomic data consists of
comprehensive biochemical descriptions of each sample as
a list of metabolites with their corresponding levels. An
‘experimental group’ of multiple individuals—called bio-
logical replicates—undergo a combination of experimental
factors. Technical and ﬁnancial limitations usually lead to
considerably more measured metabolites than the number
of biological replicates.
The ‘conceptual model’ underlying most metabolomics
experiments states that an experimental manipulation may
change the levels of several metabolites. When this
manipulation is performed on several biological replicates,
their response should be similar to the other replicates, up
to a certain deviation caused by natural and technical
variation. When quantiﬁed in a linear model for one factor
with groups 1…k…K, this leads to Eq. 1.
Xk ¼ 1IklT þ 1IklT
k þ Sk fork ¼ 1...K ð1Þ
where Xk is the (Ik 9 J) matrix containing the levels of
each metabolite, indicated by 1…j…J in the biological
replicates 1k…ik…Ik of experimental group k, l is the
length J ‘centroid’ vector of all samples, vector lk the
centroid vector for group k expressed as a deviation from l;
matrix Sk contains the deviation of each individual bio-
logical replicate from vector lk; see Supplementary
Table 1 for a list of symbols used throughout the paper.
Equation 1 is generally used to quantify the signiﬁcance
of this experimental manipulation on levels of a small
subset of single metabolites. This can be done by ANOVA
(Sokal and Rohlf 1995) that estimates the treatment effects
expressed in a series of vectors lk k ¼ 1...K ðÞ : interesting
putative biomarkers are then identiﬁed as variables j for
which variation across the j-th elements of lk k ¼ 1...K ðÞ
is high relative to the natural and technical variation of the
biological replicates derived from Sk. The model in Eq. 1
does not make any assumptions about the relationships
between metabolites, which falls in the realm of the com-
ponent analysis paradigm.
2.1 Multivariate components
A major objective in metabolomics is to understand the
underlying biochemical system, which makes observation
of the variations in each individual metabolite insufﬁcient.
The relations between different metabolites may both lead
to a more parsimonious model—the biochemical system
will constrain the complexity of the metabolic changes
resulting from the experiment—and may lead to hitherto
unknown relations between the metabolites that will pro-
vide a better insight into the observed system (Jansen et al.
2009c).
To model these system-wide relationships metabolomics
embraced the multivariate ‘component’ paradigm that
models the relationships between all J metabolite descrip-
tors (Fig. 1b). The ‘standard’ methods in this ﬁeld may also
be expressed using the partitioning of the variation in Eq. 1.
Principal Component Analysis simultaneously describes lk
and Sk, so that this model will give a convoluted description
of the paradigms in Fig. 1b, c. The often-used method
Partial Least Squares-Discriminant Analysis (PLS-DA)
aims—like ANOVA—to describe lk at the expense of the
‘biological variation’ (inter-individual variation, natural
variation) in matrix Sk. Clearly, thereby PLS-DA does
exactly the opposite of what is of interest to BMRs.
The analysis of BMRs requires separation of the varia-
tion in lk from that in Sk, because the BMR-related infor-
mation (between the individual biological replicates) is
contained only in the latter matrix. Therefore a component
analysis method needs to be developed that focuses on the
relations between the metabolites within this contribution.
2.2 Between Metabolite Relationships
In characterising BMRs, the strength of relationship
between metabolites is of high interest. However, also how
much variation in each experimental group is associated
with this relationship is important. Although Pearson cor-
relations are widely used in metabolomics, they overlook
this aspect, because in Pearson correlations the variation in
1 The book that this chapter appeared in is out-of-print and difﬁcult to
obtain. However, it can be found online in PDF format: http://publish.
uwo.ca/*harshman/abstract.html.
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123the levels of both metabolites is scaled by their standard
deviations. Therefore covariances are the preferred mea-
sure for BMRs.
A BMR-describing component model should focus upon
the differences between groups in the systematic part of the
biological variation. This information is hidden in Sk,
speciﬁcally in the relationships between the metabolites.
A view on BMRs therefore necessarily revolves around
quantifying relations between the columns of Sk. This can
be done by covariances, like in Eq. 2.
Rk ¼ I 1
k ST
k Sk ð2Þ
where Rk is the covariance matrix of experimental group
k with dimensions (J 9 J).
Because interpreting Rk may be tedious for many
metabolite covariances, the holistic and simple view of a
component model of BMRs may be highly desirable.
2.3 Individual differences scaling
A component model for BMRs needs to describe the
relations between metabolites, rather than the levels
themselves as well as possible. An existing component
model that does just this is INdividual Differences
SCALing (INDSCAL) model (Kruskal and Wish 1978;
Harshman and Lundy 1984; Carroll 1981; Carroll and
Chang, 1970), which is given in Eq. 3.
Model Rk ¼AGkAT þEk
Minimization f A;Gk ðÞ ¼
P K
k¼1
Rk  AGkAT        2
Constraints diag ATA
  
¼1R; Gk
is diagonal with nonnegative elements ð3Þ
where Gk is an (R 9 R) score matrix of group k; matrix
A of size (J 9 R) contains the chemical loadings; Ek
contains the residuals of which the sum-of-squares is
minimized. The constraints are imposed to arrive at iden-
tiﬁed and meaningful solutions.
The INDSCAL model loadings A describe the important
relations between metabolites and the scores Gk describe
the magnitude of the variation of these relations within
each experimental group, such that both important aspects
of the BMRs are described.
The INDSCAL model is strongly related to Parallel
Factor Analysis (PARAFAC) (Bro 1997; Harshman 1970;
Smilde et al. 2004), an often-used component model in
metabolomics. The INDSCAL model can be ﬁtted by
modelling the covariance matrices Rk (arranged in a
(R 9 J 9 J) three-way array) by PARAFAC (ten Berge
and Kiers 1991). The additional nonnegativity constraint on
Gk can be straightforwardly imposed by publicly available
software (Andersson and Bro 2000). Like PARAFAC, the
components of an INDSCAL model are unique.
2.4 Model visualization and interpretation
Conventionally,theINDSCALloadingsAareshowninsuch
awaythathighloadingvaluesrelatetotherelevanceofthose
metabolites in the BMRs important on each component.
However, it may be better interpretable to rearrange the
loadings following the structure of the covariance matrices,
i.e. Rk ¼
PR
r¼1 gkraraT
r þ Ek ¼
PR
r¼1 gkrAr þ Ek, where
the matrices Ar of dimensions J 9 J are symmetric. Then
high values in Ar directly indicate important relations
betweenmetabolites.Itmaythereforebeeasiertointerpreta
heat map of Ar than a conventional loading plot of A to
identify relevant metabolites. However, since such heat
maps do not allow comparison between components in one
ﬁgure,bothmaybeofvaluetogaininsightintheBMRs.The
scores Gk (or rather the diagonal elements gkr) show for
which group k the relations in Ar are important. A score of
zero implies that the corresponding relations are absent in
group k.
Just like in PARAFAC, the components ﬁtted for
INDSCAL are not orthogonal. The amount of information
explained by the model can therefore only be calculated for
the entire model. Furthermore, adding INDSCAL compo-
nents modiﬁes all other components (Smilde et al. 2004),
which means a proper number of components has to be
chosen before interpreting the model.
2.5 Number of components, stability and validation
The amount of information each component adds to the
model may be used to determine the appropriate number of
INDSCAL components, by comparing the information
explained in a model to those with fewer components.
Whether the ﬁtted model is prone to local optima can be
tested by using multiple random starting values: the models
need to be comparable, otherwise the model may contain
too many components, thereby covering technical or other
non-systematic variation.
Because the INDSCAL model describes entire experi-
mental groups rather than individual biological replicates,
the signiﬁcance of observed effects is not expressed in the
scores Gk. An earlier-proposed jack-knife approach relies
heavily on distributional assumptions (Weinberg et al.
1984), not likely fulﬁlled by metabolomics data. Therefore
we quantify this signiﬁcance by resampling: the results (i.e.
scores and loadings) of models where individual biological
replicates are left out are compared to the original model,
which shows how individual replicates inﬂuence the
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123model. This resampling strategy is fully explained in the
supplementary material. Also a schematic pipeline to
describe BMRs by INDSCAL is given there (Supplemen-
tary Fig. 1).
3 Materials and methods
3.1 Induced plant response study data set
This experiment studied the ‘induced plant response’ of
cabbage plants to simulated herbivory to the plant shoot
(SJA) or root (RJA), by the plant hormone jasmonic acid.
These plants were compared to control (CON) plants, not
treated with the hormone. The defense was characterized
by the glucosinolate compound class: 11 compounds were
proﬁled in plants harvested at 1, 7 and 14 days after the
simulated attacks. The dataset contains 6–10 replicate
plants per herbivory type/harvest time. This study was
described in much more detail in an earlier paper (Jansen
et al. 2009b).
3.2 Human nutritional intervention study data set
In a double-blinded, placebo-controlled nutritional inter-
vention study with a parallel design, 186 human subjects
with abdominal obesity (BMI 25–35 kg/m
2 and a waist
circumference of over 80 cm for women or 95 cm for men)
consumed either catechin-enriched green tea extract drink
(GTE; 600 mg catechins/day, 87 subjects) or a placebo
drink (placebo, green tea-ﬂavoured drink without any active
ingredients, 99 subjects) over a period of 12 weeks. The
experiment was conducted at University of Nottingham
and approved by the University of Nottingham Medical
School Ethics Committee. Fasted serum samples were
collected at the baseline (start of the experiment; T0) and
after 4, 8 and 12 weeks of intervention (T4, T8 and T12).
For each serum sample a metabolic proﬁle was obtained,
composed of 136 lipid metabolites expressed as ratios
between the peak areas of the metabolite and internal
standard. The supplementary material contains a descrip-
tion of the analytical method and Supplementary Table 2
lists the measured metabolites.
3.3 Software
All statistical analyses were carried out in MATLAB 2009a
(The Mathworks Inc., Natick, Massachusetts, USA), using
in-house routines, partly based on the N-way Toolbox
(Andersson and Bro 2000). They have been made available
on www.bdagroup.nl.
4 Results and discussion
4.1 Induced plant response study—comparison of PCA
and INDSCAL results
In the ‘‘induced plant response’’ study, the metabolic effect
of shoot herbivory (SJA) or root herbivory (RJA) are of
interest. Initially a PCA model was ﬁtted, slightly modiﬁed
to exclude the average time-proﬁle of all plants related to
uninteresting chemical variation (see earlier paper: Jansen
et al. 2009b). The results of this analysis are given (again)
in Supplementary Fig. 2.
The PCA results have been described in great detail in
the earlier paper and are only brieﬂy repeated here. The
induced response to jasmonic acid consists of an increase
in Glucobrassicin (GBC) and Neoglucobrassicin (NEO) for
both treatments, but considerably larger for SJA. The RJA
plants have higher levels of Progoitrin (PRO) and Gluco-
brassicanapin (GBN) after 7 and 14 days (PC 3). These
changes are consistent for all the plants in the relevant
treatment-time combinations and will therefore end up in
lk in Eq. 1. The increase in NEO and GBC will differ
between plants, but the model also revealed that SJA plants
harvested after 7 and 14 days with more NEO, contain less
GBC, this will typically end up in matrix Sk of Eq. 1 and
therefore be the target of INDSCAL analysis. The earlier
study also showed the increase in PRO and GBN levels in
RJA plants after 7 and 14 days is preceded by an increase
in the natural variation of these levels, which should also
be revealed by INDSCAL.
A 4-component INDSCAL model explains a highly
unstable amount of information (see Table 1), leading to
three-components. This INDSCAL model (Fig. 2) corre-
sponds very well to the PCA results. The ﬁrst component
explains a BMR in the SJA plants that increases from
absence to an enormous contribution 14 days after harvest
and explains the high NEO with low GBC levels (see
Fig. 2c). The positive relation between PRO and GBN,
Table 1 Number of components for INDSCAL model of plant data
set
# components % convergence % variance
explained
1 100 92
2 100 97
3 100 99
4 80 99.5
5 55 99.7
The second column shows how many models converged to a stable
solution and the third how much information is described by the
model
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123expected to be high speciﬁcally high 1 day after RJA is
indeed present in the second INDSCAL component
(Fig. 2d). The component is also important 14 days after
SJA, which after further inspection of the large conﬁdence
interval on the PCA scores. The third INDSCAL compo-
nent describes the consistently larger variation in NEO and
in GBC related to the natural variation between the dif-
ferent SJA (1–14 days) and RJA plants (1–7 days) descri-
bed by the ﬁrst PCA component (Fig. 2e). In this data set,
the qualitatively observed BMRs in the earlier PCA model
could be quantiﬁed in the INDSCAL model.
4.2 Example of human nutritional metabolomics study
and BMRs
In this section, BMR analysis is applied on lipid proﬁles
from obese human subjects consuming either green tea
extract (GTE) or placebo during 12 weeks. Changes in the
lipidome were expected, because dietary supplementation
of GTE has been proposed as a strategy for weight loss
(Maki et al. 2009; Kovacs and Mela 2006). It has been
hypothesized to promote lipolysis as a mechanism by
which GTE stimulates fat oxidation (Westerterp-Plantenga
Fig. 2 INDSCAL model of
plant data set. a Group scores
for component 1 vs. component
2, b Group scores for
component 2 vs. component 3,
circles refer to control group
(CON), squares to root
herbivory (RJA) and crosses to
shoot herbivory (SJA). Loading
are presented as heatplots
separately for each component:
c loadings for component 1,
d loadings for component 2 and
e loadings for component 3
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1232010) and to affect lipid metabolism by inhibiting lipid
absorption and digestion (Koo and Noh 2007).
The effect of GTE on the lipid proﬁles was analysed by
investigating changes in individual metabolite levels, in
multi-metabolite proﬁles and in BMR components ﬁtted by
INDSCAL. Variables were not scaled and INDSCAL was
performed with covariances to compare all results to each
other.
4.2.1 Changes in individual metabolite levels
Univariate, nonparametric U-Mann–Whitney statistic tests
(Sokal and Rohlf 1995) did not reveal any statistically
signiﬁcant changes in individual metabolite levels between
T12 (end of intervention period) and T0 (baseline) (see
Supplementary Table 3), for either GTE or placebo. This
indicates GTE did not induce an effect stronger than the
inter-individual variation. This is frequently observed in
dietary intervention studies within healthy human subjects,
where effects are typically subtle and obscured by large
inter-individual variations.
4.2.2 Proﬁles of multiple metabolites
An unsupervised PCA model did not reveal any relevant
difference between GTE and placebo groups (see Supple-
mentary Fig. 3). A supervised PLS-DA model also did not
provide statistically signiﬁcant differences between the
GTE and placebo group metabolite proﬁles between T0
and T12 (see Supplementary Table 4). A multiway-PLS-
DA (N-PLS-DA) was employed to simultaneously evaluate
time-related metabolic changes induced by GTE at all four
time points (Bro 1996; Castro and Manetti 2007), while
retaining the structure of the repeated measurements on the
same individuals (Smilde et al. 2010). The diagnostic
outcome of this model was very weak: e.g. 47.1% of the
samples were misclassiﬁed (see Supplementary Table 4).
This shows GTE intervention did not change the serum
lipid proﬁles signiﬁcantly as observed by the ‘standard’
multivariate data analysis methods most widely used in
metabolomics (Jansen et al. 2009c; Trygg et al. 2007;
Lindon et al. 2000; Holmes et al. 2000).
4.2.3 Between Metabolite Relationships
To include all available a priori knowledge about the
experimental design into the INDSCAL model, a ‘baseline’
group (BL) was constructed of all individuals measured at
the start of the experiment (T0), assuming all subjects to
belong to a homogeneous population before the nutri-
tional intervention. For the remaining samples, covariance
matrices were calculated for each experimental groups,
i.e. treatment and measurement time-point combination:
GTE-T4, GTE-T8, GTE-T12, placebo-T4, placebo-T8 and
placebo-T12.
To determine the number of INDSCAL components
appropriate to model these covariance matrices, one to ﬁve
components were ﬁtted 20 times, starting from random
values. Table 2 shows the percentages of explained infor-
mation and of converged models. This table shows that the
model requires two components, because 20% of the
models with three components did not converge to a stable
solution.
The INDSCAL scores of the GTE group (black circles
in Fig. 3a) differ from those of the placebo group (white
circles) after 4, 8 and 12 weeks of intervention and from
the BL group (grey circle). The ﬁrst INDSCAL component
mainly describes a systematic drift of the GTE group from
the region of the plot covered by the placebo group and the
second component shows an additional variation in the
BMRs of the GTE group, prominent at T4 (Fig. 3a).
The resampling results (conﬁdence intervals around the
circles in Fig. 3a) show that the differences between GTE
and placebo are highly signiﬁcant after 4 and 12 weeks and
that after 8 weeks the resampling interval of GTE has only
very slight overlap with that of BL. The resampling results
of the chemical loadings (intervals around the circles in
Fig. 3b) show that the BMR response to GTE consists of
the covariance between metabolites TG28, TG29, TG41
and TG42.
The ﬁrst INDSCAL component is of most interest in this
study, because it shows a consistent GTE-associated drift.
The heat plot in Fig. 3c focuses upon these loadings. This
heat plot shows BMRs rather than the contributions of the
individual lipids to the loadings in Fig. 3b. The heat plot
quantiﬁes the BMRs in greyscale, showing for example
that the covariance between TGs 28 and 29 is larger than
between TGs 54 and 42, considerably less interpretable
from Fig. 3b alone.
Table 2 Number of components for INDSCAL model for human
nutritional data set
# components % convergence % variance
explained
1 100 97.1
2 100 99.0
3 80 99.4
4 60 99.6
5 70 99.8
The second column shows how many models converged to a stable
solution and the third how much information is described by the
model
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1234.3 Selected lipids: level changes and BMRs
The effect of GTE on the plasma lipids is clearly visible
in both INDSCAL model representations in Fig. 3.I ti s
mainly associated with relations between a very small
subset of lipids. Most important are the triacylglycerols
TG28-29 and TG41-42. Figure 4a shows that the variance
of TG29 (those for TGs 28, 41 and 42 are comparable and
not shown) is signiﬁcantly affected by GTE compared to
the control and the BL groups, although the mean group
levels of these metabolites did not change (Supplementary
Fig. 4). The Pearson correlation coefﬁcients for these lipids
did not change between GTE and placebo (see Supple-
mentary Table 5), but the covariances did (Fig. 4b; Sup-
plementary Fig. 4). The barplot in Fig. 4b corresponds
closely to the INDSCAL scores (Fig. 3a). The INDSCAL
results and the (co)variance plots show that the effect of
GTE manifested itself by a systematic increase of the
covariance between TG28 and TG29 during the entire
study period and an additional increase of the covariance
between TG41 and TG42 during the ﬁrst 4 weeks of
intervention, described by the second INDSCAL compo-
nent. The last is related to a large inter-individual
difference in time and magnitude of response at the
beginning of the intervention.
4.4 Interpretation of the observed GTE effect
The INDSCAL model shows that supplementation of GTE
signiﬁcantly affects relationships between a small subset of
triacyloglycerols (see Supplementary Table 6 for the iso-
mer composition). Similar TGs have been reported to play
an important role in diet-induced weight loss for metabolic
syndrome in a 33-week intervention (Schwab et al. 2008).
These changes were not shown by the standard uni- and
multivariate statistical analyses, because these focus upon
responses in metabolite levels similar for all treated indi-
viduals (i.e. PLS-DA or Mann–Whitney tests). Figures 3
and 4 show the observed BMRs relate to an increase in the
variation in the levels of selected triacyloglycerols between
subjects that received the same intervention.
Observed changes in metabolite covariances show that
their changes are dependent between metabolites and
therefore the observed effect of GTE can be explained on
a system biology level. Inter-individual variation in the
levels of selected triacylglycerols could be related to
Fig. 3 INDSCAL model of
human nutrition data set.
a Group scores: the white
circles indicated the placebo
group, the black the GTE group
and the grey the common
baseline group (sampled before
start of intervention). The
region around each score is
obtained during model
validation and refers to region
of plot where 95% scores
obtained from resampled
models occurred. b Loadings
with regions of conﬁdence
obtained during model
validation analogously as for
scores. c Heat plot of BMRs in
greyscale; both inserts focus on
the relations of TG28 with 29
and of TG54 with 42: these are
indicated by the white frames
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123individual differences in the activities of transcription
factors or enzymes regulating these metabolites (individual
phenotype). Depending on the characteristics of the indi-
vidual phenotype, GTE could induce the increase or
decrease of these speciﬁc metabolite levels (see Supple-
mentary material for a simulation example). For example,
it has been stated that there is a wide variability in the
ﬂavonoid O-methylation by catechol-O-methyltransferase
(COMT), a key enzyme that is hypothesized to be involved
in fat oxidation and whose activity may differ between
ethnic groups (Westerterp-Plantenga 2010). Alternatively,
the increase of inter-individual variation in levels of
selected triacyloglycerols can be explained by multiple
mechanisms of actions and/or active compounds present in
GTE. That may lead to opposing effects of GTE on a
network of transcription factors and enzymes and thereby
to up- and downregulation of the production of speciﬁc
metabolites and less controlled ranges of metabolite levels.
In this case, metabolic change might be the consequence of
a superposition of e.g. changes in dietary fatty acid com-
position, different mechanisms of TG activation or differ-
ent effects on the lipid species present in the TGs (Kovacs
and Mela 2006; Westerterp-Plantenga 2010).
4.5 INDSCAL and BMRs in practice
To extract BMR-related information by standard data
analysis methods may be difﬁcult (i.e. PCA) and often even
impossible (PLS-DA): these methods have a different
focus. This paper shows, by two examples of metabolomic
data sets from plant and human nutrition studies, that the
BMR-related components of INDSCAL showed an essen-
tial aspect of metabolic change that was complementary to
that obtained by standard methods. A PCA model of the
plant ‘‘induced response study’’ only showed BMR-related
change intermingled with level changes like those in
Fig. 1b. However, with INDSCAL these were directly
focused upon. In the human nutritional study, INDSCAL
revealed increases in the inter-individual variation of four
triacylglycerols upon GTE supplementation, while this (or
any other) effect of GTE could not be observed by standard
data analysis methods.
In this study, the BMRs were expressed and included in
INDSCAL as covariances, but also other dissimilarity
measures such as Pearson or Spearman correlation coefﬁ-
cients can be used for a different focus (Jansen et al. 2009a).
In fact, multidimensional scaling methods like INDSCAL
allow matrices Rk to be ﬁlled with many dissimilarity
measures, underlined by a valid distance metric (Borg and
Groenen 2010). The choice of dissimilarity measure
depends on the expected nature of the relationships, such
that INDSCAL is a highly ﬂexible tool to ﬁnd BMRs.
Covariance analysis between metabolites, as opposed to
correlations, is highly appropriate for studies where
responses are expected to be inconsistent between indi-
viduals. For example, INDSCAL directly targets the
expected variation in the response of different humans to
dietary intervention, such as that of GTE. Because not all
individuals respond to a dietary supplementation of GTE in
the same fashion or degree, covariances rather than levels
of these metabolites change when the entire experimental
group is observed. The metabolites involved in this effect
then also have a different role than in the conventional
paradigms in Fig. 1a, b: triacylglycerols of which the
covariances with other metabolites change during dietary
intervention could be used a posteriori to select the indi-
viduals from the experimental group that have a similar
metabolic response. This relates directly to the evolution-
ary constraints that were already discussed in the intro-
duction: these also rely on responses only present in a
subset of the population. The introduction of INDSCAL
also makes such patterns available to metabolomics.
The literature concerning visualisation of INDSCAL
models is sparse (with exceptions like (Chang and Carroll
1980)). The representation of Ar in heat maps is—to our
knowledge—newandconsiderablyincreasestheinsightinto
Fig. 4 Variance and covariance of selected metabolites. a Variance of TG29 and b covariance between TG28 and TG29; BL baseline group,
GTE catechin-enriched green tea extract group, placebo placebo group, signiﬁcantly different: **P\0.05 and ***P\0.01
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the conventional representation in Fig. 4. However, the
relations between metabolites represent the biochemical
reactions within the studied organisms, therefore the IND-
SCAL loadings would immensely beneﬁt from an interpre-
tation through biochemical pathways. This would connect
the Correlation Networks that until now have observed
metabolism as a series of pairwise correlations between
metabolites (Steuer et al. 2003) with component analyses
that simultaneously connect all metabolites to each other.
The synergy between Correlation Networks and INDSCAL
will be the topic of a follow-up paper.
The Between Metabolite Relationships, together with
INDSCAL, will therefore greatly enhance the amount of
biochemical information that can be obtained from ‘omics’
experiments.
5 Concluding remarks
Between Metabolite Relationships (BMRs) may reveal
systematic changes in biological systems that remain elu-
sive when only metabolite level changes are taken into
account. The Individual Differences Scaling (INDSCAL)
method is introduced here as a method to analyse these
BMRs with component models, which give a system-wide
view on the changes in relationships between all com-
pounds measured in a metabolomics study.
The results of INDSCAL can support and explain
already known metabolic changes, such as those in the
‘‘induced plant response’’ study. They can also provide
information that lays beyond the reach of standard data
analysis methods in use in metabolomics as in the human
nutritional intervention study. The BMRs indicated which
relations between metabolites are most prone to a variable
response by the biological replicates e.g. by jasmonic acid
application (subset of glucosinolates in ‘‘induced plant
response’’ study) or by the GTE intervention (subset of
triacyloglycerols in human nutritional intervention study).
Identiﬁcation of such changes in metabolite relationships
will improve the understanding of possible mechanisms of
action of tested interventions.
The BMRs, together with INDSCAL, thereby open the
door to dedicated analysis of the next generation of ques-
tions in systems biology: those that deal with personalized
medicine and individual or cohort-speciﬁc responses to
dietary change.
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